title: Illumina HiSeq 4000 sequencing; Whole-exome sequencing of genomic DNA from patient-derived melanoma cell lines resistant to either vemurafenib (PLX) or trametinib (TRA).
identifiers.namespace: Department of Molecular Biology of Cancer, Medical University of Lodz, Poland
identifiers.id: E-MTAB-7991:11_PLXR